[
    {
        "question_id": "1_B_662",
        "new_question_id": "2985",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_1491",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "L2-L3",
            "L3-L4",
            "S3-S4",
            "S1-S2",
            "L1-L2",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A patient is noted to have an absent ankle reflex. Which nerve root does this correspond to?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>S1-S2</b>. The ankle reflex, also known as the Achilles reflex, is primarily mediated through the S1 and S2 nerve roots. This reflex tests the integrity of these nerve roots, as well as the sciatic nerve which they form a part of. <br /><br /><b>L2-L3</b> is incorrect because it primarily corresponds to the hip flexion and adduction rather than ankle reflex. These nerve roots are tested through movements such as bringing the knee towards the chest (hip flexion) or moving the leg inward (adduction).<br /><br /><b>L3-L4</b> is also incorrect. The L3-L4 nerve roots are responsible for knee extension and patellar reflex, not ankle reflex. A lesion at this level would present with symptoms such as weakness in straightening the knee or a reduced or absent knee-jerk reaction.<br /><br /><b>S3-S4</b> does not correspond to the ankle reflex either. These sacral nerve roots are mainly associated with bladder function, bowel movements, sexual functions and some motor function in the foot. They can be assessed using various methods like testing anal sphincter tone or perianal sensation but not by testing ankle reflex.<br /><br />Finally, <b>L1-L2</b> is incorrect too. These lumbar nerve roots control hip flexion similar to L2-L3 and do not have a direct role in mediating the ankle jerk reflex.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A patient is noted to have an absent ankle reflex. Which nerve root does this correspond to?",
        "correct_answer": "4",
        "question_notes": "The correct answer is <b>S1-S2</b>. The ankle reflex, also known as the Achilles reflex, is primarily mediated through the S1 and S2 nerve roots. This reflex tests the integrity of these nerve roots, as well as the sciatic nerve which they form a part of. <br /><br /><b>L2-L3</b> is incorrect because it primarily corresponds to the hip flexion and adduction rather than ankle reflex. These nerve roots are tested through movements such as bringing the knee towards the chest (hip flexion) or moving the leg inward (adduction).<br /><br /><b>L3-L4</b> is also incorrect. The L3-L4 nerve roots are responsible for knee extension and patellar reflex, not ankle reflex. A lesion at this level would present with symptoms such as weakness in straightening the knee or a reduced or absent knee-jerk reaction.<br /><br /><b>S3-S4</b> does not correspond to the ankle reflex either. These sacral nerve roots are mainly associated with bladder function, bowel movements, sexual functions and some motor function in the foot. They can be assessed using various methods like testing anal sphincter tone or perianal sensation but not by testing ankle reflex.<br /><br />Finally, <b>L1-L2</b> is incorrect too. These lumbar nerve roots control hip flexion similar to L2-L3 and do not have a direct role in mediating the ankle jerk reflex.",
        "answer_order": "4",
        "answer": "4",
        "title": "Reflexes",
        "body": "The common reflexes are listed below:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Reflex</b></th><th><b>Root</b></th></tr></thead><tbody><tr><td>Ankle</td><td>S1-S2</td></tr><tr><td>Knee</td><td>L3-L4</td></tr><tr><td>Biceps</td><td>C5-C6</td></tr><tr><td>Triceps</td><td>C7-C8</td></tr></tbody></table></div>",
        "notes_hash": "cd7242825f5991955f3ca5cd113ec9e8",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5660",
        "up_votes": "27",
        "down_votes": "8",
        "column_array": [
            0,
            "113",
            "1003",
            "344",
            "3956",
            "244",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/bY0oQnflmog\" data-description=\"Introduction to how reflexes work - reflex arc, monosynaptic and polysynaptic reflexes\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"815\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/bY0oQnflmog/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/bY0oQnflmog\" data-description=\"Introduction to how reflexes work - reflex arc, monosynaptic and polysynaptic reflexes\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"815\">Introduction to how reflexes work - reflex arc, monosynaptic and polysynaptic reflexes</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1415\" data-mediaid=\"1415\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1415\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1415\" data-mediaid=\"1415\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1415\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1812",
        "new_question_id": "4850",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "9071",
        "notes_id_link": "1_1822",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Electrical cardioversion",
            "Intravenous labetalol",
            "Intravenous adenosine",
            "Intravenous amiodarone",
            "Re-attempt Valsava manoeuvre in 5 minutes",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old man presents with palpitations that began around 40 minutes ago. Other than having a stressful day at work there appears to have been no obvious trigger. He denies any chest pain or dyspnoea. An ECG shows a regular tachycardia of 180 bpm with a QRS duration of 0.10s. Blood pressure is 106/70 mmHg and oxygen saturations are 98% on room air. You ask him to perform the Valsava manoeuvre but this has no effect on the rhythm. What is the most appropriate next course of action?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>intravenous adenosine</b>. This patient is presenting with supraventricular tachycardia (SVT), specifically likely to be AV nodal re-entrant tachycardia (AVNRT) or AV re-entrant tachycardia (AVRT). The diagnosis is supported by the regular narrow complex tachycardia (QRS 0.10s) with a rate of 180 bpm. According to UK guidelines, after a failed Valsalva manoeuvre, adenosine is the first-line pharmacological treatment for stable SVT. Adenosine works by temporarily blocking AV nodal conduction, thereby interrupting the re-entry circuit.<br /><br /><b>Electrical cardioversion</b> would be inappropriate at this stage as the patient is haemodynamically stable (adequate blood pressure, good oxygen saturations, no significant symptoms). Electrical cardioversion is reserved for unstable patients with features such as shock, severe hypotension, heart failure, or chest pain.<br /><br /><b>Intravenous labetalol</b> is not the drug of choice for acute termination of SVT. While beta-blockers can be used for rate control in atrial fibrillation, they are not the first-line treatment for terminating SVT.<br /><br /><b>Intravenous amiodarone</b> would be inappropriate at this stage. Amiodarone is typically reserved for cases where other treatments have failed or in the context of structural heart disease. It has a slower onset of action and more side effects compared to adenosine.<br /><br /><b>Re-attempting the Valsalva manoeuvre</b> in 5 minutes would unnecessarily delay definitive treatment. While vagal manoeuvres are the first-line treatment for SVT, once they have failed, moving on to pharmacological treatment with adenosine is the appropriate next step according to current guidelines.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old man presents with palpitations that began around 40 minutes ago. Other than having a stressful day at work there appears to have been no obvious trigger. He denies any chest pain or dyspnoea. An ECG shows a regular tachycardia of 180 bpm with a QRS duration of 0.10s. Blood pressure is 106/70 mmHg and oxygen saturations are 98% on room air. You ask him to perform the Valsava manoeuvre but this has no effect on the rhythm. What is the most appropriate next course of action?",
        "correct_answer": "3",
        "question_notes": "The correct answer is <b>intravenous adenosine</b>. This patient is presenting with supraventricular tachycardia (SVT), specifically likely to be AV nodal re-entrant tachycardia (AVNRT) or AV re-entrant tachycardia (AVRT). The diagnosis is supported by the regular narrow complex tachycardia (QRS 0.10s) with a rate of 180 bpm. According to UK guidelines, after a failed Valsalva manoeuvre, adenosine is the first-line pharmacological treatment for stable SVT. Adenosine works by temporarily blocking AV nodal conduction, thereby interrupting the re-entry circuit.<br /><br /><b>Electrical cardioversion</b> would be inappropriate at this stage as the patient is haemodynamically stable (adequate blood pressure, good oxygen saturations, no significant symptoms). Electrical cardioversion is reserved for unstable patients with features such as shock, severe hypotension, heart failure, or chest pain.<br /><br /><b>Intravenous labetalol</b> is not the drug of choice for acute termination of SVT. While beta-blockers can be used for rate control in atrial fibrillation, they are not the first-line treatment for terminating SVT.<br /><br /><b>Intravenous amiodarone</b> would be inappropriate at this stage. Amiodarone is typically reserved for cases where other treatments have failed or in the context of structural heart disease. It has a slower onset of action and more side effects compared to adenosine.<br /><br /><b>Re-attempting the Valsalva manoeuvre</b> in 5 minutes would unnecessarily delay definitive treatment. While vagal manoeuvres are the first-line treatment for SVT, once they have failed, moving on to pharmacological treatment with adenosine is the appropriate next step according to current guidelines.",
        "answer_order": "3",
        "answer": "3",
        "title": "Supraventricular tachycardia",
        "body": "Whilst strictly speaking the term supraventricular tachycardia (SVT) refers to any tachycardia that is not ventricular in origin the term is generally used in the context of paroxysmal SVT. Episodes are characterised by the sudden onset of a narrow complex tachycardia, typically an atrioventricular nodal re-entry tachycardia (AVNRT). Other causes include atrioventricular re-entry tachycardias (AVRT) and junctional tachycardias.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg085b.png\" data-fancybox=\"gallery\" data-caption=\"ECG showing AV Nodal Re-entry Tachycardia (AVNRT) - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg085.png\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg108b.png\" data-fancybox=\"gallery\" data-caption=\"ECG showing a supraventricular tachycardia - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg108.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Management</h5><br />Acute management<br /><ul><li><span class=\"concept\" data-cid=\"9619\">vagal manoeuvres:</span><ul><li>Valsalva manoeuvre: e.g. trying to blow into an empty plastic syringe</li><li>carotid sinus massage</li></ul></li><li><span class=\"concept\" data-cid=\"9071\">intravenous adenosine</span> <ul><li><span class=\"concept\" data-cid=\"11526\">rapid IV bolus</span> of <span class=\"concept\" data-cid=\"11527\"> 6mg &rarr; if unsuccessful give 12 mg &rarr; if unsuccessful give further 18 mg</span></li><li>contraindicated in asthmatics - <span class=\"concept\" data-cid=\"12323\">verapamil</span> is a preferable option</li></ul></li><li>if vagal manoeuvres and adenosine ineffective:<ul><li><span class=\"concept\" data-cid=\"12404\">verapamil or beta-blocker</span></li><li>electrical cardioversion</li></ul></li></ul><br />Prevention of episodes<br /><ul><li>beta-blockers</li><li>radio-frequency ablation</li></ul>",
        "notes_hash": "991e2356419dd66f47cfd6fea4400b1c",
        "knowledge_graph_node_id_link": 1163,
        "concept": "Patients with SVT who are haemodynamically stable and who do not respond to vagal manoeuvres, the next step is treating with adenosine",
        "concept_percentile": "58",
        "concept_colour": "rgb(214,255,0)",
        "number_attempts": "7952",
        "up_votes": "18",
        "down_votes": "15",
        "column_array": [
            0,
            "258",
            "134",
            "6459",
            "434",
            "667",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Life in the Fast Lane</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_18\" data-linkid=\"18\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_18\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">17</span><button type=\"button\" style=\"\" id=\"link_dislike_18\" data-linkid=\"18\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_18\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://litfl.com/supraventricular-tachycardia-svt-ecg-library/\">Supraventricular tachycardia</a></td></tr></table><br><br><table style='width:100%'><tr><td>Resuscitation Council UK</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2053\" data-linkid=\"2053\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2053\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_2053\" data-linkid=\"2053\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2053\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/sites/default/files/2021-04/Tachycardia%20Algorithm%202021.pdf\">2021 Tachycardia algorithm</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/tRuvXP-H164\" data-description=\"Atrioventricular reentrant tachycardia (AVRT) & AV nodal reentrant tachycardia (AVNRT)\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"913\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/tRuvXP-H164/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/tRuvXP-H164\" data-description=\"Atrioventricular reentrant tachycardia (AVRT) & AV nodal reentrant tachycardia (AVNRT)\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"913\">Atrioventricular reentrant tachycardia (AVRT) & AV nodal reentrant tachycardia (AVNRT)</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1583\" data-mediaid=\"1583\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1583\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1583\" data-mediaid=\"1583\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1583\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sTdV8xCNbBM\" data-description=\"Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"374\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/sTdV8xCNbBM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sTdV8xCNbBM\" data-description=\"Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"374\">Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_637\" data-mediaid=\"637\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_637\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_637\" data-mediaid=\"637\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_637\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iT3cVVK74tU\" data-description=\"Intro to EKG Interpretation - Overview of Tachyarrhythmias\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"375\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/iT3cVVK74tU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iT3cVVK74tU\" data-description=\"Intro to EKG Interpretation - Overview of Tachyarrhythmias\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"375\">Intro to EKG Interpretation - Overview of Tachyarrhythmias</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_638\" data-mediaid=\"638\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_638\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_638\" data-mediaid=\"638\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_638\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/f5xC5ofq4aE\" data-description=\"Understanding Supraventricular Tachycardia (SVT)\" data-upvotes=\"24\" data-downvotes=\"1\" data-media=\"1210\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/f5xC5ofq4aE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/f5xC5ofq4aE\" data-description=\"Understanding Supraventricular Tachycardia (SVT)\" data-upvotes=\"24\" data-downvotes=\"1\" data-media=\"1210\">Understanding Supraventricular Tachycardia (SVT)</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2122\" data-mediaid=\"2122\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2122\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"media_dislike_2122\" data-mediaid=\"2122\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2122\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NULY6Ecj6gA\" data-description=\"Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification\" data-upvotes=\"4\" data-downvotes=\"2\" data-media=\"377\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/NULY6Ecj6gA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NULY6Ecj6gA\" data-description=\"Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification\" data-upvotes=\"4\" data-downvotes=\"2\" data-media=\"377\">Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_640\" data-mediaid=\"640\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_640\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_640\" data-mediaid=\"640\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_640\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cj9CtfjFdRA\" data-description=\"Atrioventricular reentrant tachycardia (AVRT) &amp; nodal reentrant tachycardia (AVNRT)\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"84\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/cj9CtfjFdRA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cj9CtfjFdRA\" data-description=\"Atrioventricular reentrant tachycardia (AVRT) &amp; nodal reentrant tachycardia (AVNRT)\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"84\">Atrioventricular reentrant tachycardia (AVRT) &amp; nodal reentrant tachycardia (AVNRT)</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_145\" data-mediaid=\"145\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_145\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_145\" data-mediaid=\"145\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_145\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pd5FF8jGR78\" data-description=\"Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"376\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/pd5FF8jGR78/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pd5FF8jGR78\" data-description=\"Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"376\">Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_639\" data-mediaid=\"639\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_639\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_639\" data-mediaid=\"639\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_639\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": {
            "9071": {
                "concept_text": "Patients with SVT who are haemodynamically stable and who do not respond to vagal manoeuvres, the next step is treating with adenosine",
                "concept_percentile": "58"
            },
            "9619": {
                "concept_text": "The first-line management of SVT is vagal manoeuvres: e.g. Valsalva manoeuvre or carotid sinus massage",
                "concept_percentile": "69"
            },
            "12404": {
                "concept_text": "If vagal manoeuvres and adenosine ineffective for SVT --> verapamil or beta-blocker",
                "concept_percentile": "99"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_3924",
        "new_question_id": "11646",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "1004",
        "notes_id_link": "1_1169",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "No antibiotic prophylaxis is indicated",
            "Oral penicillin",
            "Oral ciprofloxacin",
            "Oral azithromycin",
            "Oral doxycycline",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 55-year-old woman with a history of alcoholic liver disease is reviewed in clinic. She has advanced cirrhosis and has started to accumulate ascites. An ascitic tap was recently performed and showed a protein concentration of 12 g/L but no evidence of any organisms. <br /><br />What is the most appropriate management concerning the risk of spontaneous bacterial peritonitis?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer in this case is <b>Oral ciprofloxacin</b>. In patients with advanced cirrhosis and low ascitic fluid protein (<15 g/L), there is an increased risk of developing spontaneous bacterial peritonitis (SBP). Oral ciprofloxacin is a fluoroquinolone antibiotic that provides broad-spectrum coverage against Gram-negative organisms, which are the most common cause of SBP. According to UK guidelines, long-term prophylaxis with oral ciprofloxacin (or norfloxacin) should be considered for patients at high risk for SBP, such as those with a previous episode of SBP or low ascitic fluid protein concentration.<br /><br />Regarding the other options:<br /><br /><b>No antibiotic prophylaxis is indicated</b> would not be appropriate in this case due to the patient's increased risk for SBP based on her low ascitic fluid protein concentration and history of advanced cirrhosis.<br /><br /><b>Oral penicillin</b> is not an appropriate choice for SBP prophylaxis because it does not provide adequate coverage against Gram-negative organisms commonly implicated in SBP, such as <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>.<br /><br /><b>Oral azithromycin</b>, a macrolide antibiotic, is also not suitable for SBP prophylaxis as it primarily targets Gram-positive bacteria and atypical organisms. It does not have sufficient activity against Gram-negative bacteria frequently associated with SBP.<br /><br />Finally, <b>Oral doxycycline</b>, a tetracycline antibiotic, provides broader coverage than penicillin but still lacks optimal effectiveness against the typical causative organisms of SBP. Moreover, doxycycline has potential hepatotoxic effects which could further worsen liver function in a patient with advanced cirrhosis.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 55-year-old woman with a history of alcoholic liver disease is reviewed in clinic. She has advanced cirrhosis and has started to accumulate ascites. An ascitic tap was recently performed and showed a protein concentration of 12 g/L but no evidence of any organisms. <br /><br />What is the most appropriate management concerning the risk of spontaneous bacterial peritonitis?",
        "correct_answer": "3",
        "question_notes": "The correct answer in this case is <b>Oral ciprofloxacin</b>. In patients with advanced cirrhosis and low ascitic fluid protein (<15 g/L), there is an increased risk of developing spontaneous bacterial peritonitis (SBP). Oral ciprofloxacin is a fluoroquinolone antibiotic that provides broad-spectrum coverage against Gram-negative organisms, which are the most common cause of SBP. According to UK guidelines, long-term prophylaxis with oral ciprofloxacin (or norfloxacin) should be considered for patients at high risk for SBP, such as those with a previous episode of SBP or low ascitic fluid protein concentration.<br /><br />Regarding the other options:<br /><br /><b>No antibiotic prophylaxis is indicated</b> would not be appropriate in this case due to the patient's increased risk for SBP based on her low ascitic fluid protein concentration and history of advanced cirrhosis.<br /><br /><b>Oral penicillin</b> is not an appropriate choice for SBP prophylaxis because it does not provide adequate coverage against Gram-negative organisms commonly implicated in SBP, such as <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>.<br /><br /><b>Oral azithromycin</b>, a macrolide antibiotic, is also not suitable for SBP prophylaxis as it primarily targets Gram-positive bacteria and atypical organisms. It does not have sufficient activity against Gram-negative bacteria frequently associated with SBP.<br /><br />Finally, <b>Oral doxycycline</b>, a tetracycline antibiotic, provides broader coverage than penicillin but still lacks optimal effectiveness against the typical causative organisms of SBP. Moreover, doxycycline has potential hepatotoxic effects which could further worsen liver function in a patient with advanced cirrhosis.",
        "answer_order": "3",
        "answer": "3",
        "title": "Spontaneous bacterial peritonitis",
        "body": "Spontaneous bacterial peritonitis (SBP) is a form of peritonitis usually seen in patients with ascites secondary to liver cirrhosis.<br /><br /><span class=\"concept\" data-cid=\"10051\">Features</span><br /><ul><li>ascites</li><li>abdominal pain</li><li>fever</li></ul><br />Diagnosis<br /><ul><li>paracentesis: <span class=\"concept\" data-cid=\"1488\">neutrophil count > 250 cells/ul</span></li><li>the most common organism found on ascitic fluid culture is <span class=\"concept\" data-cid=\"5499\"><i>E. coli</i></span></li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"192\">intravenous cefotaxime</span> is usually given</li></ul><br />Antibiotic prophylaxis should be given to patients with ascites if:<br /><ul><li>patients who have <span class=\"concept\" data-cid=\"4464\">had an episode of SBP</span></li><li>patients with fluid protein <15 g/l and either Child-Pugh score of at least 9 or hepatorenal syndrome</li><li>NICE recommend: '<i>Offer prophylactic <span class=\"concept\" data-cid=\"1004\">oral ciprofloxacin or norfloxacin</span> for people with cirrhosis and ascites with an ascitic protein of 15 g/litre or less until the ascites has resolved</i>'</li></ul><br />Alcoholic liver disease is a marker of poor prognosis in SBP.",
        "notes_hash": "bb71667950305cbbb90a1f3df17c1e82",
        "knowledge_graph_node_id_link": 0,
        "concept": "Patients with ascites (and protein concentration <= 15 g/L) should be given oral ciprofloxacin or norfloxacin as prophylaxis against spontaneous bacterial peritonitis",
        "concept_percentile": "93",
        "concept_colour": "rgb(35,255,0)",
        "number_attempts": "5539",
        "up_votes": "36",
        "down_votes": "32",
        "column_array": [
            0,
            "2066",
            "201",
            "2691",
            "426",
            "155",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>European Association for the Study of the Liver</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1605\" data-linkid=\"1605\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1605\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1605\" data-linkid=\"1605\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1605\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://easl.eu/wp-content/uploads/2018/10/Hepatorenal-Cirrhosis-English-report.pdf\">2010 EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis</a></td></tr></table><br><br><table style='width:100%'><tr><td>British Society of Gastroenterology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_744\" data-linkid=\"744\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_744\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_744\" data-linkid=\"744\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_744\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.bsg.org.uk/wp-content/uploads/2020/10/gutjnl-2020-321790.full_.pdf\">Guidelines on the management of ascites in cirrhosis</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Igb1rta3-c4\" data-description=\"Spontaneous bacterial peritonitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1406\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Igb1rta3-c4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Igb1rta3-c4\" data-description=\"Spontaneous bacterial peritonitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1406\">Spontaneous bacterial peritonitis</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2473\" data-mediaid=\"2473\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2473\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2473\" data-mediaid=\"2473\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2473\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 13,
        "concepts_for_notes": {
            "1004": {
                "concept_text": "Patients with ascites (and protein concentration <= 15 g/L) should be given oral ciprofloxacin or norfloxacin as prophylaxis against spontaneous bacterial peritonitis",
                "concept_percentile": "93"
            },
            "1488": {
                "concept_text": "In suspected SBP- diagnosis is by paracentesis. Confirmed by neutrophil count >250 cells/ul",
                "concept_percentile": "88"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4285_B_5",
        "new_question_id": "15798",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "4070",
        "notes_id_link": "1_329",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Administer anti-VEGF injections",
            "Refer to ophthalmology urgently within 1 week",
            "Refer to ophthalmology within 1 month",
            "Prescribe multi-vitamins",
            "Prescribe atorvastatin 40mg",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 78-year-old gentleman was seen in your GP clinic during your FY2 rotation in General Practice. He complained of blurring of vision in the right eye for the past 4 months but finally decided to come to see you because he felt his vision is now very distorted. On dilated fundoscopy, the left eye is normal. In the right eye, you can see drusen at the macula. You suspected age-related macular degeneration. <br /><br />Which ONE of the following is your next step in management?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "When you suspect AMD, it is crucial you refer to ophthalmology urgently within 1 week to get a formal diagnosis because if the diagnosis is wet AMD it can be treated with anti-VEGF injections and will improve the patient's long-term visual outcome. In this case, even though drusen is present and is more suggestive of dry AMD, the referral should still be done urgently within 1 week. <br /><br />Administer anti-VEGF injections is a treatment for wet AMD but not dry AMD. Referring to Ophthalmology within 1 month will delay the formal diagnosis and commencement of treatment in this patient. Multi-vitamins may be useful in dry AMD but is not the next step in management. Atorvastatin is used to lower blood cholesterol level and will not help in treating drusen.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 78-year-old gentleman was seen in your GP clinic during your FY2 rotation in General Practice. He complained of blurring of vision in the right eye for the past 4 months but finally decided to come to see you because he felt his vision is now very distorted. On dilated fundoscopy, the left eye is normal. In the right eye, you can see drusen at the macula. You suspected age-related macular degeneration. <br /><br />Which ONE of the following is your next step in management?",
        "correct_answer": "2",
        "question_notes": "When you suspect AMD, it is crucial you refer to ophthalmology urgently within 1 week to get a formal diagnosis because if the diagnosis is wet AMD it can be treated with anti-VEGF injections and will improve the patient's long-term visual outcome. In this case, even though drusen is present and is more suggestive of dry AMD, the referral should still be done urgently within 1 week. <br /><br />Administer anti-VEGF injections is a treatment for wet AMD but not dry AMD. Referring to Ophthalmology within 1 month will delay the formal diagnosis and commencement of treatment in this patient. Multi-vitamins may be useful in dry AMD but is not the next step in management. Atorvastatin is used to lower blood cholesterol level and will not help in treating drusen.",
        "answer_order": "2",
        "answer": "2",
        "title": "Age-related macular degeneration",
        "body": "Age-related macular degeneration is the most common cause of blindness in the UK. Degeneration of the central retina (macula) is the key feature with changes usually bilateral. ARMD is characterised by degeneration of retinal photoreceptors that results in the formation of drusen which can be seen on fundoscopy and retinal photography. It is more common with advancing age and is more common in females.<br /><br />Risk factors<br /><ul><li>advancing age itself is the greatest risk factor for ARMD<ul><li>the risk of ARMD increases 3 fold for patients aged older than 75 years, versus those aged 65-74.</li></ul></li><li><span class=\"concept\" data-cid=\"640\">smoking</span><ul><li>current smokers are twice as likely as non-smokers to have ARMD related visual loss, and ex-smokers have a slightly increased risk of developing the condition, (OR 1.13). </li></ul></li><li>family history is also a strong risk factor for developing ARMD<ul><li>first degree relatives of a sufferer of ARMD are thought to be four times more likely to inherit the condition.</li></ul></li><li>other risk factors for developing the condition include those associated with an increased risk of ischaemic cardiovascular disease, such as hypertension, dyslipidaemia and diabetes mellitus. </li></ul><br /><br /><h5 class='notes-heading'>Classification</h5><br />Traditionally two forms of macular degeneration are seen:<br /><ul><li>dry macular degeneration<ul><li>90% of cases</li><li>also known as atrophic</li><li>characterised by <span class=\"concept\" data-cid=\"639\">drusen</span>  - yellow round spots in Bruch's membrane</li></ul></li><li>wet macular degeneration<ul><li>10% of cases</li><li>also known as exudative or neovascular macular degeneration</li><li>characterised by <span class=\"concept\" data-cid=\"11900\">choroidal neovascularisation</span></li><li>leakage of serous fluid and blood can subsequently result in a rapid loss of vision</li><li>carries the worst prognosis</li></ul></li></ul><br />Recently there has been a move to a more updated classification:<br /><ul><li>early age-related macular degeneration (non-exudative, age-related maculopathy): drusen and alterations to the retinal pigment epithelium (RPE)</li><li>late age-related macular degeneration (neovascularisation, exudative)</li></ul><br /><h5 class='notes-heading'>Clinical features</h5><br />Patients typically present with a subacute onset of visual loss with:<br /><ul><li>a reduction in visual acuity, particularly for near field objects<ul><li>gradual in dry ARMD </li><li>subacute in wet ARMD</li></ul></li><li><span class=\"concept\" data-cid=\"12500\">worse in the centre of vision</span> (e.g. difficulty reading, recognising faces, driving)</li><li>difficulties in dark adaptation with an overall deterioration in vision at night</li><li>fluctuations in visual disturbance which may vary significantly from day to day</li><li>they may also suffer from photopsia, (a perception of flickering or flashing lights), and glare around objects</li><li>visual hallucinations may also occur resulting in Charles-Bonnet syndrome</li></ul><br />Signs:<br /><ul><li>distortion of line perception may be noted on <span class=\"concept\" data-cid=\"11392\">Amsler grid testing</span></li><li>fundoscopy reveals the presence of drusen, yellow areas of pigment deposition in the macular area, which may become confluent in late disease to form a macular scar.</li><li>in wet ARMD well demarcated red patches may be seen which represent intra-retinal or sub-retinal fluid leakage or haemorrhage. </li></ul>   <br />Investigations:<br /><ul><li>slit-lamp microscopy is the initial investigation of choice, to identify any pigmentary, exudative or haemorrhagic changes affecting the retina which may identify the presence of ARMD. This is usually accompanied by colour fundus photography to provide a baseline against which changes can be identified over time.</li><li>fluorescein angiography is utilised if neovascular ARMD is suspected, as this can guide intervention with anti-VEGF therapy. This may be complemented with indocyanine green angiography to visualise any changes in the choroidal circulation. </li><li>optical coherence tomography is used to visualise the retina in three dimensions because it can reveal areas of disease which aren't visible using microscopy alone. </li></ul><br /><h5 class='notes-heading'>Management</h5><br />Treatment<br /><ul><li>the AREDS trial examined the treatment of dry ARMD in 3640 subjects. It showed that a combination of zinc with anti-oxidant vitamins A,C and E reduced progression of the disease by around one third. Patients with more extensive drusen seemed to benefit most from the intervention. Treatment is therefore recommended in patients with at least moderate category dry ARMD. </li><li><span class=\"concept\" data-cid=\"4069\">vascular endothelial growth factor (VEGF)</span> <ul><li>VEGR is a potent mitogen and drives increased vascular permeability in patients with wet ARMD</li><li>a number of trials have shown that use of anti-VEGF agents can limit progression of wet ARMD and stabilise or reverse visual loss</li><li>evidence suggests that they should be instituted within the first two months of diagnosis of wet ARMD if possible</li><li>examples of anti-VEGF agents include ranibizumab, <span class=\"concept\" data-cid=\"11448\">bevacizumab</span> and pegaptanib,. The agents are usually administered by 4 weekly injection. </li></ul></li><li>laser photocoagulation does slow progression of ARMD where there is new vessel formation, although there is a risk of acute visual loss after treatment, which may be increased in patients with sub-foveal ARMD. For this reason anti-VEGF therapies are usually preferred.</li></ul>",
        "notes_hash": "09af800e13bb1ef3f1990b7d53bc66af",
        "knowledge_graph_node_id_link": 1286,
        "concept": "Referral to ophthalmology urgently within 1 week if suspecting AMD",
        "concept_percentile": "97",
        "concept_colour": "rgb(15,255,0)",
        "number_attempts": "3993",
        "up_votes": "49",
        "down_votes": "63",
        "column_array": [
            0,
            "243",
            "1731",
            "815",
            "1155",
            "49",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Webvision</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_410\" data-linkid=\"410\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_410\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">42</span><button type=\"button\" style=\"\" id=\"link_dislike_410\" data-linkid=\"410\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_410\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">42</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://webvision.med.utah.edu/book/part-xii-cell-biology-of-retinal-degenerations/age-related-macular-degeneration-amd/\">Age related macular degeneration fundoscopy findings</a></td></tr></table>",
        "media": "",
        "comment_count": 7,
        "concepts_for_notes": {
            "639": {
                "concept_text": "<b>D</b>rusen = <b>D</b>ry macular degeneration",
                "concept_percentile": "67"
            },
            "640": {
                "concept_text": "Macular degeneration - smoking is risk factor",
                "concept_percentile": "80"
            },
            "11392": {
                "concept_text": "Amsler grid testing (to check for distortion of line perception) may be useful in testing patients with suspected age related macular degeneration",
                "concept_percentile": "85"
            },
            "12500": {
                "concept_text": "Elderly patient, gradual, central visual loss --> age-related macular degeneration",
                "concept_percentile": "100"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1669",
        "new_question_id": "2935",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "310",
        "notes_id_link": "1_1474",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "<i>Lactobacilli</i>",
            "<i>Trichomonas</i>",
            "<i>Candida</i>",
            "<i>Mycoplasma hominis</i>",
            "<i>Gardnerella</i>",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 30-year-old woman presents with a white, malodorous vaginal discharge. There is no associated itch or dyspareunia. A diagnosis of bacterial vaginosis is suspected.<br /><br />Overgrowth of which one of the following organisms is most likely to cause this presentation?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The correct answer in this case is <b><i>Gardnerella</i></b>. Bacterial vaginosis (BV) is a condition characterized by an imbalance of the normal vaginal flora, with a reduction in the number of <i>Lactobacilli</i> and overgrowth of anaerobic bacteria, primarily <i>Gardnerella vaginalis</i>. This overgrowth results in the production of a white, malodorous discharge which is typically non-irritating and not associated with itch or dyspareunia, as described in the clinical scenario.<br /><br />Now let's discuss why the other options are incorrect:<br /><br /><b><i>Lactobacilli</i></b> are actually part of the normal vaginal flora and produce lactic acid, which helps to maintain an acidic environment that inhibits the growth of pathogenic organisms. A decrease in <i>Lactobacilli</i> levels can predispose to bacterial vaginosis, but they are not responsible for causing the symptoms.<br /><br /><b><i>Trichomonas</i></b>, specifically <i>Trichomonas vaginalis</i>, is a protozoan parasite that causes trichomoniasis. While it may present with a malodorous discharge, it typically also causes itching, burning sensation during urination, and dyspareunia - features that were not mentioned in this scenario.<br /><br /><b><i>Candida</i></b>, usually <i>Candida albicans</i>, is responsible for causing vulvovaginal candidiasis (VVC), also known as thrush. VVC usually presents with thick, white 'cottage cheese-like' discharge along with significant itching and irritation. The absence of these symptoms makes this option less likely.<br /><br />Finally, <b><i>Mycoplasma hominis</i></b> can be found as part of the normal vaginal flora, but it can also be associated with some cases of bacterial vaginosis. However, <i>Mycoplasma hominis</i> is not considered the primary causative organism in BV and is less likely to cause the presentation described compared to <i>Gardnerella vaginalis</i>.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 30-year-old woman presents with a white, malodorous vaginal discharge. There is no associated itch or dyspareunia. A diagnosis of bacterial vaginosis is suspected.<br /><br />Overgrowth of which one of the following organisms is most likely to cause this presentation?",
        "correct_answer": "5",
        "question_notes": "The correct answer in this case is <b><i>Gardnerella</i></b>. Bacterial vaginosis (BV) is a condition characterized by an imbalance of the normal vaginal flora, with a reduction in the number of <i>Lactobacilli</i> and overgrowth of anaerobic bacteria, primarily <i>Gardnerella vaginalis</i>. This overgrowth results in the production of a white, malodorous discharge which is typically non-irritating and not associated with itch or dyspareunia, as described in the clinical scenario.<br /><br />Now let's discuss why the other options are incorrect:<br /><br /><b><i>Lactobacilli</i></b> are actually part of the normal vaginal flora and produce lactic acid, which helps to maintain an acidic environment that inhibits the growth of pathogenic organisms. A decrease in <i>Lactobacilli</i> levels can predispose to bacterial vaginosis, but they are not responsible for causing the symptoms.<br /><br /><b><i>Trichomonas</i></b>, specifically <i>Trichomonas vaginalis</i>, is a protozoan parasite that causes trichomoniasis. While it may present with a malodorous discharge, it typically also causes itching, burning sensation during urination, and dyspareunia - features that were not mentioned in this scenario.<br /><br /><b><i>Candida</i></b>, usually <i>Candida albicans</i>, is responsible for causing vulvovaginal candidiasis (VVC), also known as thrush. VVC usually presents with thick, white 'cottage cheese-like' discharge along with significant itching and irritation. The absence of these symptoms makes this option less likely.<br /><br />Finally, <b><i>Mycoplasma hominis</i></b> can be found as part of the normal vaginal flora, but it can also be associated with some cases of bacterial vaginosis. However, <i>Mycoplasma hominis</i> is not considered the primary causative organism in BV and is less likely to cause the presentation described compared to <i>Gardnerella vaginalis</i>.",
        "answer_order": "5",
        "answer": "5",
        "title": "Bacterial vaginosis",
        "body": "Bacterial vaginosis (BV) describes an overgrowth of predominately anaerobic organisms such as <span class=\"concept\" data-cid=\"310\"><i>Gardnerella vaginalis</i></span>. This leads to a consequent fall in lactic acid producing aerobic lactobacilli resulting in a raised vaginal pH.<br /><br />Whilst BV is not a sexually transmitted infection it is seen almost exclusively in sexually active women.<br /> <br />Features<br /><ul><li>vaginal discharge: 'fishy', offensive</li><li>asymptomatic in 50%</li></ul><br />Amsel's criteria for diagnosis of BV - 3 of the following 4 points should be present<br /><ul><li>thin, white homogenous discharge</li><li>clue cells on microscopy: stippled vaginal epithelial cells</li><li><span class=\"concept\" data-cid=\"5255\">vaginal pH > 4.5</span></li><li>positive whiff test (addition of potassium hydroxide results in fishy odour)</li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"1679\">if the woman is asymptomatic, treatment is not usually required</span> #link33 <ul><li>e.g. picked up on a swab done for different reasons</li><li>exceptions include if a woman is undergoing a termination of pregnancy</li></ul></li><li>if symptomatic: <span class=\"concept\" data-cid=\"309\">oral metronidazole for 5-7 days</span> #link34 <ul><li>70-80% initial cure rate</li><li>relapse rate > 50% within 3 months</li><li>a single oral dose of metronidazole  2g may be used if adherence may be an issue</li><li>the BNF suggests topical metronidazole or <span class=\"concept\" data-cid=\"8946\">topical clindamycin</span> as alternatives</li></ul></li><li><span class=\"concept\" data-cid=\"311\">if pregnant</span> #link32 <ul><li>results in an increased risk of preterm labour, low birth weight and chorioamnionitis, late miscarriage</li><li>it was previously taught that oral metronidazole should be avoided in the first trimester and topical clindamycin used instead. Recent guidelines however recommend that oral metronidazole is used throughout pregnancy</li><li>if asymptomatic: discuss with the woman's obstetrician if treatment is indicated</li><li>if symptomatic: either oral metronidazole for 5-7 days or topical treatment. The higher, stat dose of metronidazole mentioned above is not recommended</li></ul></li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Comparison of bacterial vaginosis and <i>Trichomonas vaginalis</i></div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002.jpg'/></a></td></tr><tr><td valign='top' align='left'><span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from PathoPic</span></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Clue cells -  epithelial cells develop a stippled appearance due to being covered with bacteria</div>",
        "notes_hash": "6bbe9a840b81afcdad0fbdc4f14af87b",
        "knowledge_graph_node_id_link": 1212,
        "concept": "Bacterial vaginosis - overgrowth of predominately <i>Gardnerella vaginalis</i>",
        "concept_percentile": "41",
        "concept_colour": "rgb(255,209,0)",
        "number_attempts": "4157",
        "up_votes": "22",
        "down_votes": "9",
        "column_array": [
            0,
            "485",
            "438",
            "189",
            "43",
            "3002",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RGLGy6r423s\" data-description=\"Bacterial vaginosis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"516\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/RGLGy6r423s/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RGLGy6r423s\" data-description=\"Bacterial vaginosis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"516\">Bacterial vaginosis</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_896\" data-mediaid=\"896\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_896\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_896\" data-mediaid=\"896\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_896\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NLef45tE3Vc\" data-description=\"Bacterial vaginosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1555\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/NLef45tE3Vc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NLef45tE3Vc\" data-description=\"Bacterial vaginosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1555\">Bacterial vaginosis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2709\" data-mediaid=\"2709\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2709\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2709\" data-mediaid=\"2709\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2709\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "309": {
                "concept_text": "Bacterial vaginosis: oral metronidazole",
                "concept_percentile": "65"
            },
            "310": {
                "concept_text": "Bacterial vaginosis - overgrowth of predominately <i>Gardnerella vaginalis</i>",
                "concept_percentile": "41"
            },
            "311": {
                "concept_text": "Bacterial vaginosis in pregnancy: still use oral metronidazole",
                "concept_percentile": "65"
            },
            "8946": {
                "concept_text": "Topical clindamycin is an alternative to metronidazole for patients with bacterial vaginosis",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1474",
        "new_question_id": "5602",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_1888",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Prolonged migraines (e.g. 24-48 hours)",
            "Strictly unilateral symptoms",
            "Hemiplegia",
            "Good response to metoclopramide",
            "Gastrointestinal disturbance",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A mother brings her 9-year-old daughter into surgery. She has been having recurrent headaches. Which one of the following features of migraine is more common in children?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "Nausea, vomiting and abdominal pain are common in children with migraine.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A mother brings her 9-year-old daughter into surgery. She has been having recurrent headaches. Which one of the following features of migraine is more common in children?",
        "correct_answer": "5",
        "question_notes": "Nausea, vomiting and abdominal pain are common in children with migraine.",
        "answer_order": "5",
        "answer": "5",
        "title": "Migraine: diagnostic criteria",
        "body": "The International Headache Society has produced the following diagnostic criteria for migraine without aura:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Point</b></th><th><b>Criteria</b></th></tr></thead><tbody><tr><td><b>A</b></td><td>At least 5 attacks fulfilling criteria B-D</td></tr><tr><td><b>B</b></td><td>Headache attacks lasting 4-72 hours* (untreated or unsuccessfully treated)</td></tr><tr><td><b>C</b></td><td>Headache has at least two of the following characteristics:<br /><ul><li>1. unilateral location*</li><li>2. pulsating quality (i.e., varying with the heartbeat)</li><li>3. moderate or severe pain intensity</li><li>4. aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs)</td></tr><tr><td></li></ul><b>D</b></td><td>During headache at least one of the following:<br /><ul><li>1. nausea and/or vomiting*</li><li>2. photophobia and phonophobia</td></tr><tr><td></li></ul><b>E</b></td><td>Not attributed to another disorder (history and examination do not suggest a secondary headache disorder or, if they do, it is ruled out by appropriate investigations or headache attacks do not occur for the first time in close temporal relation to the other disorder)</td></tr></tbody></table></div><br />*In children, attacks may be shorter-lasting, headache is more commonly bilateral, and gastrointestinal disturbance is more prominent.<br /><br />Migraine with aura (seen in around 25% of migraine patients) tends to be easier to diagnose with a typical aura being progressive in nature and may occur hours prior to the headache. Typical aura include a transient hemianopic disturbance or a spreading scintillating scotoma ('jagged crescent'). Sensory symptoms may also occur<br /><br />If we compare these guidelines to the <b>NICE criteria</b> the following points are noted:<br /><ul><li>NICE suggests migraines may be unilateral or bilateral</li><li>NICE also give more detail about typical auras:</li></ul><br />Auras may occur with or without headache and:<br /><ul><li>are fully reversible</li><li>develop over at least 5 minutes</li><li>last 5-60 minutes</li></ul><br />The following aura symptoms are atypical and may prompt further investigation/referral;<br /><ul><li>motor weakness</li><li>double vision</li><li>visual symptoms affecting only one eye</li><li>poor balance</li><li>decreased level of consciousness.</li></ul>",
        "notes_hash": "c7c209740766f0b28742dea99edaecc1",
        "knowledge_graph_node_id_link": 1016,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5305",
        "up_votes": "36",
        "down_votes": "18",
        "column_array": [
            0,
            "361",
            "369",
            "155",
            "203",
            "4217",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>International Headache Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1478\" data-linkid=\"1478\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1478\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1478\" data-linkid=\"1478\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1478\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.ihs-headache.org/binary_data/3245_ichd-3-cephalalgia-2018-issue-1.pdf\">2019 The International Classification of Headache Disorders</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Ekz-4bl66xk\" data-description=\"Migraine\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1421\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Ekz-4bl66xk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Ekz-4bl66xk\" data-description=\"Migraine\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1421\">Migraine</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2497\" data-mediaid=\"2497\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2497\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2497\" data-mediaid=\"2497\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2497\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/D2litdZhfzY\" data-description=\"Migraine\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"103\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/D2litdZhfzY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/D2litdZhfzY\" data-description=\"Migraine\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"103\">Migraine</a></td></tr><tr><td><span ><small>Podmedics - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_177\" data-mediaid=\"177\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_177\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_177\" data-mediaid=\"177\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_177\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1704",
        "new_question_id": "9328",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_582",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Wolff-Parkinson White syndrome",
            "Right bundle branch block",
            "First degree heart block",
            "Inferior myocardial ischaemia",
            "Normal ECG",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A middle-aged man presents with central chest pain. This has been since present this morning and is described as 'severe' and 'burning'. Examination of the cardiovascular system is unremarkable with a heart rate of 84/min, blood pressure of 148/92 mmHg and oxygen saturations of 98% on room air. You obtain an ECG:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What does the ECG show?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "This is a normal ECG. T wave inversion in III is a normal variant.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A middle-aged man presents with central chest pain. This has been since present this morning and is described as 'severe' and 'burning'. Examination of the cardiovascular system is unremarkable with a heart rate of 84/min, blood pressure of 148/92 mmHg and oxygen saturations of 98% on room air. You obtain an ECG:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg054c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What does the ECG show?",
        "correct_answer": "5",
        "question_notes": "This is a normal ECG. T wave inversion in III is a normal variant.",
        "answer_order": "5",
        "answer": "5",
        "title": "ECG: normal variants",
        "body": "The following ECG changes are considered normal variants in an athlete:<br /><ul><li>sinus bradycardia</li><li>junctional rhythm</li><li><span class=\"concept\" data-cid=\"2802\">first degree heart block</span></li><li><span class=\"concept\" data-cid=\"11726\">Mobitz type 1 (Wenckebach phenomenon)</span></li></ul>",
        "notes_hash": "eb1084ac166691e4c6376b20ab1bb6de",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "7488",
        "up_votes": "50",
        "down_votes": "39",
        "column_array": [
            0,
            "906",
            "351",
            "535",
            "694",
            "5002",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u1m3HKW1VqU\" data-description=\"ECG Interpretation Made Easy\" data-upvotes=\"26\" data-downvotes=\"1\" data-media=\"1478\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/u1m3HKW1VqU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u1m3HKW1VqU\" data-description=\"ECG Interpretation Made Easy\" data-upvotes=\"26\" data-downvotes=\"1\" data-media=\"1478\">ECG Interpretation Made Easy</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2607\" data-mediaid=\"2607\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2607\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">26</span><button type=\"button\" style=\"\" id=\"media_dislike_2607\" data-mediaid=\"2607\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2607\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": {
            "2802": {
                "concept_text": "First-degree heart block is a normal variant in an athlete. It does not require intervention ",
                "concept_percentile": "63"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_1452",
        "new_question_id": "59648",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "2960",
        "notes_id_link": "1_1243",
        "theme": "COC efficacy in women on enzyme-inducing antiepileptics",
        "instruction": "",
        "options": [
            "",
            "The COC may be less effective due to her current medication",
            "The COC remains fully effective if taken correctly",
            "The COC is contraindicated with epilepsy",
            "Efficacy is only reduced if she misses a pill",
            "She should avoid all hormonal contraception",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 27-year-old woman attends your GP surgery for contraceptive advice. She has a history of epilepsy, well controlled on carbamazepine. She is keen to start the combined oral contraceptive pill (COC). Her menstrual cycles are regular and she has no contraindications to oestrogen. Which statement best describes the efficacy of the COC in her situation?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>The COC may be less effective due to her current medication</b>: This is the correct answer. Carbamazepine is an enzyme-inducing antiepileptic drug that increases hepatic metabolism of oestrogens and progestogens, reducing the efficacy of the combined oral contraceptive pill. UK guidelines (FSRH) recommend additional precautions or alternative methods for women taking enzyme-inducing drugs such as carbamazepine, as pregnancy risk is increased.<br /><br /><b>The COC remains fully effective if taken correctly</b>: This is incorrect because even perfect use does not overcome drug interactions from enzyme induction. Enzyme inducers accelerate hormone breakdown regardless of adherence, so efficacy cannot be guaranteed.<br /><br /><b>The COC is contraindicated with epilepsy</b>: This statement is inaccurate; epilepsy itself does not contraindicate use of the combined pill unless there are specific seizure types or comorbidities (such as migraine with aura). The issue here relates to drug interaction rather than the underlying diagnosis.<br /><br /><b>Efficacy is only reduced if she misses a pill</b>: While missed pills do reduce effectiveness, this answer ignores important pharmacological interactions. In this case, efficacy can be compromised even without missed doses due to increased hepatic clearance from carbamazepine.<br /><br /><b>She should avoid all hormonal contraception</b>: This overstates the case\u2014some forms of hormonal contraception (e.g., copper IUDs or higher-dose progestogen-only injections) remain suitable for women on enzyme-inducing drugs. The key issue here concerns oral preparations affected by hepatic metabolism.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 27-year-old woman attends your GP surgery for contraceptive advice. She has a history of epilepsy, well controlled on carbamazepine. She is keen to start the combined oral contraceptive pill (COC). Her menstrual cycles are regular and she has no contraindications to oestrogen. Which statement best describes the efficacy of the COC in her situation?",
        "correct_answer": "1",
        "question_notes": "<b>The COC may be less effective due to her current medication</b>: This is the correct answer. Carbamazepine is an enzyme-inducing antiepileptic drug that increases hepatic metabolism of oestrogens and progestogens, reducing the efficacy of the combined oral contraceptive pill. UK guidelines (FSRH) recommend additional precautions or alternative methods for women taking enzyme-inducing drugs such as carbamazepine, as pregnancy risk is increased.<br /><br /><b>The COC remains fully effective if taken correctly</b>: This is incorrect because even perfect use does not overcome drug interactions from enzyme induction. Enzyme inducers accelerate hormone breakdown regardless of adherence, so efficacy cannot be guaranteed.<br /><br /><b>The COC is contraindicated with epilepsy</b>: This statement is inaccurate; epilepsy itself does not contraindicate use of the combined pill unless there are specific seizure types or comorbidities (such as migraine with aura). The issue here relates to drug interaction rather than the underlying diagnosis.<br /><br /><b>Efficacy is only reduced if she misses a pill</b>: While missed pills do reduce effectiveness, this answer ignores important pharmacological interactions. In this case, efficacy can be compromised even without missed doses due to increased hepatic clearance from carbamazepine.<br /><br /><b>She should avoid all hormonal contraception</b>: This overstates the case\u2014some forms of hormonal contraception (e.g., copper IUDs or higher-dose progestogen-only injections) remain suitable for women on enzyme-inducing drugs. The key issue here concerns oral preparations affected by hepatic metabolism.",
        "answer_order": "1",
        "answer": "1",
        "title": "Combined oral contraceptive pill: counselling",
        "body": "Women who are considering taking the combined oral contraceptive pill (COC) should be counselled in a number of areas:<br /><br />Potential harms and benefits, including<br /><ul><li>the COC is > 99% effective if taken correctly</li><li>small risk of <span class=\"concept\" data-cid=\"9008\">blood clots</span></li><li>very small risk of <span class=\"concept\" data-cid=\"7798\">heart attacks</span> and <span class=\"concept\" data-cid=\"7799\">strokes</span></li><li>increased risk of <span class=\"concept\" data-cid=\"7800\">breast cancer</span> and <span class=\"concept\" data-cid=\"7801\">cervical cancer</span></li></ul><br />Advice on taking the pill, including<br /><ul><li>if the COC is started within the first 5 days of the cycle then there is no need for additional contraception. If it is started at any other point in the cycle then alternative contraception should be used (e.g. condoms) for the first 7 days  </li><li>should be taken at the same time every day</li><li>the COCP is conventionally taken for 21 days then stopped for 7 days - similar uterine bleeding to menstruation. However, there was a major change following the 2019 guidelines. 'Tailored' regimes should now be discussed with women. This is because there is <span class=\"concept\" data-cid=\"8880\">no medical benefit</span> from having a withdrawal bleed. Options include never having a pill-free interval or 'tricycling' - taking three 21 day packs back-to-back before having a 4 or 7 day break</li><li>advice that intercourse during the pill-free period is only safe if the next pack is started on time</li></ul><br />Discussion on situations where efficacy may be reduced*<br /><ul><li>if vomiting within 2 hours of taking COC pill</li><li><span class=\"concept\" data-cid=\"8886\">medication</span> that induce diarrhoea or vomiting may reduce effectiveness of oral contraception (for example orlistat)</li><li>if taking liver <span class=\"concept\" data-cid=\"2960\">enzyme-inducing drugs</span></li></ul><br />Other information<br /><ul><li>discussion on STIs</li></ul><br />*Concurrent antibiotic use<br /><ul><li>for many years doctors in the UK have advised that the concurrent use of antibiotics may interfere with the enterohepatic circulation of oestrogen and thus make the combined oral contraceptive pill ineffective - 'extra-precautions' were advised for the duration of antibiotic treatment and for 7 days afterwards</li><li>no such precautions are taken in the US or the majority of mainland Europe</li><li>in 2011 the Faculty of Sexual & Reproductive Healthcare produced new guidelines abandoning this approach. The latest edition of the BNF has been updated in line with this guidance</li><li>precautions should still be taken with enzyme inducing antibiotics such as rifampicin</li></ul>",
        "notes_hash": "837d0207732da47aa095d1e1969760ab",
        "knowledge_graph_node_id_link": 10894,
        "concept": "The efficacy of the combined oral contraceptive pill is reduced if concurrently taking enzyme-inducing drugs",
        "concept_percentile": "74",
        "concept_colour": "rgb(132,255,0)",
        "number_attempts": "4837",
        "up_votes": "7",
        "down_votes": "5",
        "column_array": [
            0,
            "3539",
            "515",
            "444",
            "130",
            "209",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Healthcare</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1473\" data-linkid=\"1473\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1473\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_1473\" data-linkid=\"1473\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1473\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">17</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.fsrh.org/documents/combined-hormonal-contraception/\">Combined oral contraceptive pill guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": {
            "2960": {
                "concept_text": "The efficacy of the combined oral contraceptive pill is reduced if concurrently taking enzyme-inducing drugs",
                "concept_percentile": "74"
            },
            "7798": {
                "concept_text": "Combined oral contraceptive pill may cause increased risk of myocardial infarction",
                "concept_percentile": "48"
            },
            "7799": {
                "concept_text": "Combined oral contraceptive pill may cause increased risk of ischaemic stroke",
                "concept_percentile": "30"
            },
            "7800": {
                "concept_text": "Combined oral contraceptive pill may cause increased risk of breast cancer",
                "concept_percentile": "75"
            },
            "7801": {
                "concept_text": "Combined oral contraceptive pill may cause increased risk of cervical cancer",
                "concept_percentile": "24"
            },
            "9008": {
                "concept_text": "The combined oral contraceptive pill is associated with an increased risk of venous thromboembolism",
                "concept_percentile": "17"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16300_B_1356",
        "new_question_id": "47264",
        "question_type": "0",
        "category": "10",
        "concept_id_link": "2567",
        "notes_id_link": "1_2276",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Absolute decrease in eGFR",
            "Absolute increase in creatinine",
            "Decrease in urine output",
            "Percentage decrease in eGFR",
            "Percentage increase in urea",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 78-year-old woman presents to the emergency department with confusion. She has a long-term catheter in situ that her son emptied 8 hours ago.<br /><br />On examination, she appears clinically dehydrated. She weighs 50kg and the catheter bag contains 250ml of urine. Blood tests are taken and compared with tests done 2 days ago:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td></td><td><b>Today</b></td><td><b>2 days ago</b></td><td></td></tr><tr><td>Urea</td><td>9.2</td><td>7.3</td><td>(2.0-7.0 mmol/L)</td></tr><tr><td>Creatinine</td><td>134</td><td>100</td><td>(55-120 \u00b5mol/L)</td></tr><tr><td>eGFR</td><td>33</td><td>47</td><td>(>90 mL/min/1.73m<sup>2</sup>)</td></tr></tbody></table></div><br />Alongside antibiotics, she is diagnosed with acute kidney injury and commenced on intravenous fluids.<br /><br />What factor supports this diagnosis?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Specific criteria are set out by NICE when diagnosing acute kidney injury (AKI). Specifically, an <b>absolute increase in creatinine</b> of 26 \u00b5mol/L or more in 48 hours justifies the diagnosis of AKI. This criterion is met here - a rise from 100 \u00b5mol/L to 134 \u00b5mol/L has been observed.<br /><br />An <b>absolute decrease in eGFR</b> is incorrect. The fall in eGFR is irrelevant with regard to AKI diagnosis. The change in creatinine is instead calculated, or the fall in urine output.<br /><br />Although a <b>decrease in urine output</b> can be used to diagnose AKI, the patient does not meet this criterion. A fall in urine output to <0.5ml/kg/hr, for more than 6 hours, is required. Based on this patient's body weight, this would equate to less than 200ml output over 8 hours. However, she has had 250ml output since her bag was emptied 8 hours ago.<br /><br />A <b>percentage decrease in eGFR</b> is incorrect. eGFR changes are not used by NICE to diagnose AKI.<br /><br />A <b>percentage increase in urea</b> is not part of the criteria used to diagnose AKI. Whilst increases in urea do correlate with reducing kidney function, it is not a reliable measurement for diagnostic purposes.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 78-year-old woman presents to the emergency department with confusion. She has a long-term catheter in situ that her son emptied 8 hours ago.<br /><br />On examination, she appears clinically dehydrated. She weighs 50kg and the catheter bag contains 250ml of urine. Blood tests are taken and compared with tests done 2 days ago:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td></td><td><b>Today</b></td><td><b>2 days ago</b></td><td></td></tr><tr><td>Urea</td><td>9.2</td><td>7.3</td><td>(2.0-7.0 mmol/L)</td></tr><tr><td>Creatinine</td><td>134</td><td>100</td><td>(55-120 \u00b5mol/L)</td></tr><tr><td>eGFR</td><td>33</td><td>47</td><td>(>90 mL/min/1.73m<sup>2</sup>)</td></tr></tbody></table></div><br />Alongside antibiotics, she is diagnosed with acute kidney injury and commenced on intravenous fluids.<br /><br />What factor supports this diagnosis?",
        "correct_answer": "2",
        "question_notes": "Specific criteria are set out by NICE when diagnosing acute kidney injury (AKI). Specifically, an <b>absolute increase in creatinine</b> of 26 \u00b5mol/L or more in 48 hours justifies the diagnosis of AKI. This criterion is met here - a rise from 100 \u00b5mol/L to 134 \u00b5mol/L has been observed.<br /><br />An <b>absolute decrease in eGFR</b> is incorrect. The fall in eGFR is irrelevant with regard to AKI diagnosis. The change in creatinine is instead calculated, or the fall in urine output.<br /><br />Although a <b>decrease in urine output</b> can be used to diagnose AKI, the patient does not meet this criterion. A fall in urine output to <0.5ml/kg/hr, for more than 6 hours, is required. Based on this patient's body weight, this would equate to less than 200ml output over 8 hours. However, she has had 250ml output since her bag was emptied 8 hours ago.<br /><br />A <b>percentage decrease in eGFR</b> is incorrect. eGFR changes are not used by NICE to diagnose AKI.<br /><br />A <b>percentage increase in urea</b> is not part of the criteria used to diagnose AKI. Whilst increases in urea do correlate with reducing kidney function, it is not a reliable measurement for diagnostic purposes.",
        "answer_order": "2",
        "answer": "2",
        "title": "Acute kidney injury: NICE guidelines and staging",
        "body": "This guideline discuss what increases the risk of AKI:<br /><ul><li>Emergency surgery, ie, risk of sepsis or hypovolaemia</li><li>Intraperitoneal surgery</li><li>CKD, ie if eGFR < 60</li><li>Diabetes</li><li>Heart failure</li><li>Age >65 years</li><li>Liver disease</li><li>Use of nephrotoxic drugs<ul><li>NSAIDs</li><li>aminoglycosides</li><li><span class=\"concept\" data-cid=\"1313\">ACE inhibitors</span>/angiotensin II receptor antagonists</li><li>diuretics</li></ul></li></ul><br /><h5 class='notes-heading'>Diagnostic criteria</h5><br />It also defines the <span class=\"concept\" data-cid=\"2567\">criteria for diagnosing AKI</span><br /><ul><li>Rise in creatinine of 26\u00b5mol/L or more in 48 hours OR</li><li>>= 50% rise in creatinine over 7 days OR</li><li>Fall in urine output to <span class=\"concept\" data-cid=\"12051\">< 0.5ml/kg/hour</span> for more than 6 hours in adults (8 hours in children) OR</li><li> >= 25% fall in eGFR in children / young adults in 7 days.</li></ul><br /><h5 class='notes-heading'>Staging criteria</h5><br />The Kidney Disease: Improving Global Outcomes (KDIGO) criteria are widely used to stage the AKI:<br /><br /><div class=\"table-responsive\"><table class = \"table table-bordered\"  ><tbody><tr><td><b><span class=\"concept\" data-cid=\"11382\">Stage 1</span></b></td><td>Increase in creatinine to <b>1.5-1.9</b> times baseline, or<br />Increase in creatinine by \u226526.5 \u00b5mol/L, or<br />Reduction in urine output to <b><0.5</b> mL/kg/hour for <b>\u2265 6 hours</b></td></tr><tr><td><b><span class=\"concept\" data-cid=\"11383\">Stage 2</span></b></td><td>Increase in creatinine to <b>2.0 to 2.9</b> times baseline, or <br />Reduction in urine output to <b><0.5</b> mL/kg/hour for <b>\u226512 hours</b></td></tr><tr><td><b><span class=\"concept\" data-cid=\"11384\">Stage 3</span></b></td><td>Increase in creatinine to <b>\u2265 3.0</b> times baseline, or <br />Increase in creatinine to \u2265353.6 \u00b5mol/L or <br />Reduction in urine output to <b><0.3</b> mL/kg/hour for <b>\u226524 hours</b>, or <br />The initiation of kidney replacement therapy, or, <br />In patients <18 years, decrease in eGFR to <35 mL/min/1.73 m2</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Referral criteria</h5><br />Refer to a nephrologist if any of the following apply:<br /><ul><li>Renal tranplant</li><li>ITU patient with unknown cause of AKI</li><li>Vasculitis/ glomerulonephritis/ tubulointerstitial nephritis/ myeloma</li><li>AKI with no known cause</li><li>Inadequate response to treatment </li><li>Complications of AKI</li><li>Stage 3 AKI (see guideline for details)</li><li>CKD stage 4 or 5</li><li>Qualify for renal replacement  hyperkalaemia / metabolic acidosis/ complications of uraemia/ fluid overload (pulmonary oedema)</li></ul>",
        "notes_hash": "a520e098bb876c3221a96649f181f470",
        "knowledge_graph_node_id_link": 10779,
        "concept": "NICE recognise any of the following criteria to diagnose AKI in adults:<br /><ul><li>\u2191 creatinine > 26\u00b5mol/L in 48 hours</li><li>\u2191 creatinine > 50% in 7 days </li><li>\u2193 urine output < 0.5ml/kg/hr for more than 6 hours</li></ul>",
        "concept_percentile": "73",
        "concept_colour": "rgb(137,255,0)",
        "number_attempts": "5481",
        "up_votes": "30",
        "down_votes": "51",
        "column_array": [
            0,
            "422",
            "2303",
            "1619",
            "914",
            "223",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Think Kidneys </td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1152\" data-linkid=\"1152\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1152\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_1152\" data-linkid=\"1152\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1152\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.thinkkidneys.nhs.uk/aki/resources/junior-doctors/\">Resources for doctors</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_472\" data-linkid=\"472\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_472\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_472\" data-linkid=\"472\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_472\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng148/chapter/Recommendations\">2019 Acute kidney injury: prevention, detection and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH1DCCqLGps\" data-description=\"Acute kidney injury\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"1146\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/MH1DCCqLGps/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH1DCCqLGps\" data-description=\"Acute kidney injury\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"1146\">Acute kidney injury</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1984\" data-mediaid=\"1984\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1984\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_1984\" data-mediaid=\"1984\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1984\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/as40yVd6Z8U\" data-description=\"Understanding Acute Kidney Injury (AKI Made Easy)\" data-upvotes=\"5\" data-downvotes=\"2\" data-media=\"1362\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/as40yVd6Z8U/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/as40yVd6Z8U\" data-description=\"Understanding Acute Kidney Injury (AKI Made Easy)\" data-upvotes=\"5\" data-downvotes=\"2\" data-media=\"1362\">Understanding Acute Kidney Injury (AKI Made Easy)</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2393\" data-mediaid=\"2393\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2393\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_2393\" data-mediaid=\"2393\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2393\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "2567": {
                "concept_text": "NICE recognise any of the following criteria to diagnose AKI in adults:\n   - \u2191 creatinine > 26\u00b5mol/L in 48 hours\n   - \u2191 creatinine > 50% in 7 days \n   - \u2193 urine output < 0.5ml/kg/hr for more than 6 hours",
                "concept_percentile": "73"
            },
            "11382": {
                "concept_text": "KDIGO AKI stage 1\n   - \u2191 creatinine 1.5-1.9 times, or\n   - \u2193 urine output <0.5 mL/kg/hr for \u2265 6 hours",
                "concept_percentile": "70"
            },
            "12051": {
                "concept_text": "If a patient has a urine output of < 0.5ml/kg/hr postoperatively the first step is to consider a fluid challenge, if there are no contraindications or signs of haemorrhage etc",
                "concept_percentile": "88"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2165",
        "new_question_id": "6842",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_2277",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Condoms",
            "Progestogen only pill",
            "Intrauterine system (e.g. Mirena)",
            "Injectable contraceptives (e.g. Depo-Provera)",
            "Implantable contraceptive (e.g. Nexplanon)",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Which one of the following contraceptives do the Faculty of Sexual and Reproductive Healthcare (FSRH) recommend should be discontinued after the age of 50 years?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Depo-Provera (the progestogen-only injectable contraceptive) is not recommended for routine use in women over the age of 50, according to the Faculty of Sexual and Reproductive Healthcare (FSRH). This is primarily due to concerns about its long-term effects on bone mineral density. While the loss of bone density may be reversible in younger women, postmenopausal women are already at increased risk of osteoporosis, and further suppression of oestrogen can exacerbate this risk.<br /><br />Additionally, after the age of 50, fertility declines significantly, and women should ideally be transitioned to methods that allow better assessment of menopausal status. Unlike the injectable, methods such as the progestogen-only pill (POP) or intrauterine system (IUS) can be continued beyond 50 with periodic review and are preferred due to a more favourable risk profile.<br /><br />In contrast, condoms, POPs, and implants may continue to be used beyond age 50 depending on the individual\u2019s preferences, medical history, and ongoing contraceptive needs. However, for Depo-Provera, the FSRH advises that it should be discontinued at age 50 and an alternative method considered.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Which one of the following contraceptives do the Faculty of Sexual and Reproductive Healthcare (FSRH) recommend should be discontinued after the age of 50 years?",
        "correct_answer": "4",
        "question_notes": "Depo-Provera (the progestogen-only injectable contraceptive) is not recommended for routine use in women over the age of 50, according to the Faculty of Sexual and Reproductive Healthcare (FSRH). This is primarily due to concerns about its long-term effects on bone mineral density. While the loss of bone density may be reversible in younger women, postmenopausal women are already at increased risk of osteoporosis, and further suppression of oestrogen can exacerbate this risk.<br /><br />Additionally, after the age of 50, fertility declines significantly, and women should ideally be transitioned to methods that allow better assessment of menopausal status. Unlike the injectable, methods such as the progestogen-only pill (POP) or intrauterine system (IUS) can be continued beyond 50 with periodic review and are preferred due to a more favourable risk profile.<br /><br />In contrast, condoms, POPs, and implants may continue to be used beyond age 50 depending on the individual\u2019s preferences, medical history, and ongoing contraceptive needs. However, for Depo-Provera, the FSRH advises that it should be discontinued at age 50 and an alternative method considered.",
        "answer_order": "4",
        "answer": "4",
        "title": "Contraception for women aged > 40 years",
        "body": "Whilst fertility has usually significantly declined by the age of 40 years women still require effective contraception until the menopause. The Faculty of Sexual and Reproductive Healthcare (FSRH) have produced specific guidance looking at this age group - 'Contraception for Women Aged Over 40 Years' - a link is provided below.<br /><br /><h5 class='notes-heading'>Specific methods</h5><br />No method of contraception is contraindicated by age alone. All methods are UKMEC1 except for the combined oral contraceptive pill (UKMEC2 for women >= 40 years) and Depo-Provera (UKMEC2 for women > 45 years). The guidance issued by the FSRH contained a number of points which should be considered about each method:<br /><br />Combined oral contraceptive pill (COCP)<br /><ul><li>COCP use in the perimenopausal period may help to maintain bone mineral density</li><li>COCP use may help reduce menopausal symptoms</li><li>a pill containing < 30 \u00b5g ethinylestradiol may be more suitable for women > 40 years</li></ul><br />Depo-Provera<br /><ul><li>women should be advised there may be a delay in the return of fertility of up to 1 year for women > 40 years</li><li>use is associated with a small loss in bone mineral density which is usually recovered after discontinuation</li></ul><br /><h5 class='notes-heading'>Stopping contraception</h5><br />The FSRH have produced a useful table detailing how the different methods may be stopped. Please follow the link for the full table.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Method</th><th>Women < 50 years</th><th>Women >= 50 years</th></tr></thead><tbody><tr><td>Non-hormonal (e.g. IUD, condoms, natural family planning)</td><td>Stop contraception after 2 years of amenorrhoea</td><td>Stop contraception after 1 year of amenorrhoea</td></tr><tr><td>COCP</td><td>Can be continued to 50 years</td><td>Switch to non-hormonal or progestogen-only method</td></tr><tr><td>Depo-Provera</td><td>Can be continued to 50 years</td><td>Switch to either a non-hormonal method and stop after 2 years of amenorrhoea OR switch to a progestogen-only method and follow advice below</td></tr><tr><td>Implant, POP, IUS</td><td>Can be continued beyond 50 years</td><td>Continue<br /><br />If amenorrhoeic check FSH and stop after 1 year if FSH >= 30u/l or stop at 55 years<br /><br />If not amenorrhoeic consider investigating abnormal bleeding pattern</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Hormone Replacement Therapy and Contraception</h5><br />As we know hormone replacement therapy (HRT) cannot be relied upon for contraception so a separate method of contraception is needed. The FSRH advises that the POP may be be used with in conjunction with HRT as long as the HRT has a progestogen component (i.e. the POP cannot be relied upon to 'protect' the endometrium). In contrast the IUS is licensed to provide the progestogen component of HRT.",
        "notes_hash": "f6efd105f4b5eacc0bcf5b6d0c4ea51b",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4607",
        "up_votes": "7",
        "down_votes": "2",
        "column_array": [
            0,
            "54",
            "895",
            "612",
            "2357",
            "689",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Healthcare</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_469\" data-linkid=\"469\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_469\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">22</span><button type=\"button\" style=\"\" id=\"link_dislike_469\" data-linkid=\"469\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_469\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.fsrh.org/standards-and-guidance/documents/fsrh-guidance-contraception-for-women-aged-over-40-years-2017/\">Contraception for Women Aged Over 40 Years</a></td></tr></table>",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    }
]